silybin has been researched along with Dyslipidemias in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, SL; Liu, L; Liu, ZQ; Mai, CT; Wang, H; Xie, Y; Zheng, YF; Zhou, H | 1 |
| Muthumani, M; Prabu, SM | 1 |
2 other study(ies) available for silybin and Dyslipidemias
| Article | Year |
|---|---|
Suppression of up-regulated LXRα by silybin ameliorates experimental rheumatoid arthritis and abnormal lipid metabolism.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Line; Cytokines; Dyslipidemias; Enzymes; Gene Expression Regulation; Hepatocytes; Humans; Lipid Metabolism; Lipogenesis; Liver; Liver X Receptors; Male; NF-kappa B; Rats, Sprague-Dawley; Silybin; Up-Regulation | 2021 |
Silibinin potentially attenuates arsenic-induced oxidative stress mediated cardiotoxicity and dyslipidemia in rats.
Topics: Adenosine Triphosphatases; Animals; Antioxidants; Arsenites; Disease Models, Animal; Dyslipidemias; Heart Diseases; Heme Oxygenase (Decyclizing); Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Lipids; Mitochondria, Heart; Myocardium; NADPH Oxidases; NF-E2-Related Factor 2; Oxidative Stress; Rats; Silybin; Silymarin; Sodium Compounds | 2014 |